Integrin β4 Antibody (Rabbit mAb) [A13J24]

Catalog No.: F4858

    Application: Reactivity:

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:250
    Application
    WB, IHC
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Mouse, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    202 kDa 210 kDa, 200 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    Integrin β4 Antibody (Rabbit mAb) [A13J24] detects endogenous levels of total Integrin β4 protein.
    Clone
    A13J24
    Synonym(s)
    CD104, Integrin beta-4, GP150, ITGB4
    Background
    Integrin β4 is a non-conventional β integrin subunit that pairs almost exclusively with integrin α6 to form the α6β4 heterodimer, a laminin receptor that organizes hemidesmosomes and also acts as a signaling hub linking the extracellular matrix to intracellular pathways controlling adhesion, survival, and migration in epithelial tissues and carcinomas. The α6β4 complex spans the plasma membrane with a classical integrin ectodomain that binds laminin-332 in the basement membrane, but β4 is distinguished by an unusually long cytoplasmic tail containing multiple fibronectin type III–like domains and tyrosine-rich regulatory motifs, which provide docking sites for cytolinker proteins such as plectin and BPAG1e in stable hemidesmosomes and for signaling molecules when the receptor is mobilized into motile structures. Hemidesmosome assembly is initiated by β4 through its cytoplasmic association with plectin, which connects the integrin to keratin intermediate filaments, while the extracellular α6β4 head engages laminin, thereby creating an anchoring unit that confers strong mechanical linkage between basal keratinocytes and the basement membrane; genetic ablation of β4 in mice eliminates hemidesmosomes, causes downregulation of α6, results in fragile attachment of stratified epithelia to the basal lamina, and leads to tissue disorganization reminiscent of junctional epidermolysis bullosa. Growth factor and chemokine signaling pathways can trigger phosphorylation-dependent remodeling of the β4 cytoplasmic tail, including protein kinase C–driven events that uncouple α6β4 from hemidesmosomal complexes and promote its redistribution to actin-rich lamellipodia and filopodia, where the integrin participates in dynamic adhesion turnover and drives chemotactic migration on laminin-containing matrices. Within these motile structures, β4 engages signaling networks that integrate with receptor tyrosine kinases; β4 forms complexes with c-Met and other receptors, and a key tyrosine residue in the β4 cytodomain (Y1494) controls recruitment and activation of Shp2 and Src, leading to sustained activation of downstream effectors such as Ras–ERK and PI3K–Akt, which support anchorage-independent growth and enhanced invasive behavior under hepatocyte growth factor stimulation. This dual capacity to nucleate hemidesmosomes under homeostatic conditions and to switch into a signaling-competent, migration-promoting state under growth factor or stress cues positions integrin β4 as a central regulator of epithelial plasticity, coordinating the balance between stable adhesion and motility. In clinical specimens, elevated expression or mislocalization of α6β4 from hemidesmosomes into nonjunctional membrane domains correlates with aggressive behavior and poor prognosis in several malignancies, including breast, colorectal, and lung cancers, and β4-dependent signaling is linked to enhanced survival under detachment stress and to increased invasion through basement membrane–like barriers.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください